| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
In the medical imaging industry, AI is primarily used to analyze medical images (like X-rays, MRIs, CT scans) more quickly and accurately than traditional methods. |
Still. While AI can support administrative automation or research, its main function in medical imaging is enhancing diagnostic accuracy and outcomes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
A key benefit of AI in radiology is that it can serve as a second medical opinion by providing additional analysis of medical images. |
This helps radiologists Double-check findings, Detect subtle abnormalities, Reduce diagnostic errors, Improve overall confidence in diagnoses. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
AI literacy refers to a person’s understanding of how AI works, its capabilities, limitations, and implications. |
It means having enough knowledge to interact effectively with AI tools, critically evaluate AI outputs, and make informed decisions about their use. This is essential as AI becomes more integrated into many fields, including healthcare. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of AI machines is irrelevant and not a factor influencing healthcare professionals' acceptance of AI. |
Acceptability depends on meaningful aspects like Trust in AI’s accuracy and reliability or Their overall receptiveness to new technology. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
According to the article, social influence—such as opinions from colleagues, leadership support, and professional norms—plays a significant role in shaping healthcare professionals’ willingness to adopt and use AI tools. |
Positive social endorsement can increase trust and acceptance, while skepticism or negative attitudes in the professional community can hinder AI uptake. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
A common perceived threat regarding AI usage in healthcare is the fear that AI might replace healthcare professionals, leading to job insecurity. |
Many worry that automation and AI decision-making could reduce the need for human clinicians, despite AI being intended to assist rather than replace them. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
The article emphasizes that designing human-centred AI systems is essential to increase acceptability among medical professionals. |
While high algorithmic performance and cost are important, the focus on human-centred design ensures AI tools are practical, trusted, and well integrated into healthcare settings, which is key for adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
These factors directly influence whether healthcare professionals find the AI system usable and are willing to incorporate it into their practice. |
Other options like personal preferences alone, geographic location, age, or insurance type are not specifically part of the ‘system usage’ category as defined in the article. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethicality influences AI acceptability because healthcare professionals evaluate whether AI systems align with their professional values, ethical standards, and patient care principles. |
If AI is perceived as violating privacy, fairness, or patient autonomy, it lowers trust and acceptance. Ethical concerns go beyond legal compliance and are deeply tied to clinicians' moral responsibility and commitment to patients. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
The article emphasizes that future studies on AI acceptability should deeply consider user experience and how well AI systems integrate into existing clinical workflows. This approach helps understand practical challenges, usability issues, and real-world adoption barriers from the perspective of healthcare professionals. |
Focusing only on economic factors or prioritizing speed over accuracy ignores critical human and workflow factors. Limiting AI use to large hospitals is a narrow view and not a methodological recommendation. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson’s disease primarily involves the loss of dopamine-producing neurons in a specific brain area called the substantia nigra |
Using human embryonic stem cells aims to generate new dopamine neurons that can be transplanted to replace those lost, helping to restore normal motor function. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Non-human primates, such as monkeys, are commonly used in preclinical studies for neurological treatments |
because their brain structure and function are more similar to humans compared to rodents. Testing safety and efficacy in monkeys provides more relevant data before moving to human trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
This duration allows researchers to assess both short- and longer-term safety outcomes before progressing to further stages of development. |
- |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The clinical trial for STEM-PD is described as a Phase I/IIa study, which typically combines early-stage safety evaluation (Phase I) with preliminary assessments of efficacy (Phase IIa). |
This phased approach is common for novel therapies to efficiently gather initial safety and effectiveness data. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM-PD product is manufactured under Good Manufacturing Practice (GMP)-compliant conditions, which ensures that the product is produced with consistent quality, safety, and regulatory standards suitable for clinical use. |
Other options like spontaneous differentiation, non-GMP conditions, random integration, or skipping regulatory testing would not meet the stringent requirements for clinical-grade products. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
The safety of the STEM-PD product in rats was confirmed because the study found no adverse effects such as toxicity, immune reactions, or tumor formation after transplantation. This indicates the product is safe for further development. |
The other options describe negative outcomes that would have disqualified the product from progressing. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The efficacy study showed that STEM-PD transplanted cells differentiated into dopamine neurons and functionally integrated, leading to a reversal of motor deficits in Parkinson’s disease rat models. |
Other options indicate failure or negative effects, which were not observed in the study. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
LMX1A and EN1 |
|
LMX1A and EN1 are transcription factors specifically associated with the development of midbrain dopaminergic neurons, the target cell type for Parkinson’s therapy. Assessing these markers confirms the purity and correct differentiation of the STEM-PD batch toward the desired neuronal lineage. |
Other markers like OCT4 and NANOG are pluripotency markers (undifferentiated cells), SOX1 and PAX6 are neural progenitor markers, and FOXA2/OTX2 are early developmental markers but less specific for midbrain dopamine neurons. GIRK2 and ALDH1A1 are also dopaminergic neuron markers but LMX1A and EN1 are the primary markers used here. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
Growth factors like FGF8b (Fibroblast Growth Factor 8b) and SHH (Sonic Hedgehog) are crucial in the developmental signaling pathways that guide stem cells to differentiate into specific neural lineages—in this case, midbrain dopaminergic neurons. During the manufacturing of STEM-PD, these factors help pattern the cells to adopt the correct neural fate necessary for effective Parkinson’s treatment. |
They do not prevent differentiation, initiate apoptosis, or enhance pluripotency, but rather direct differentiation towards a desired cell type. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
A key outcome in the preclinical efficacy trials for STEM-PD was the recovery of motor function in Parkinson’s disease rat models. Since Parkinson’s primarily affects motor control due to loss of dopamine neurons, improvement in motor abilities directly indicates the therapeutic effectiveness of the transplanted cells. |
Other options like anxiety behaviors, cognitive abilities, lifespan, or brain size were not primary efficacy measures in these trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|